CTD // Fund
Verge Fund
Investor in early-stage healthcare technology companies
← Fund directoryVerge Fund is an institutional investor (Healthcare Startups) founded in 2018 and headquartered in Singapore, Singapore. Investor in early-stage healthcare technology companies. This firm focuses exclusively on healthcare technologies, providing capital to companies developing transformative solutions across various areas, including clinical decision support, digital therapeutics, and diagnostic tools. The investment strategy targets companies aiming to improve healthcare accessibility, quality, and efficiency. The portfolio includes a diverse range of technologies at different stages of development, from pre-regulatory to revenue-generating.
- Stage
- seed, Series A, pre-seed, seed, Series A, pre-seed
- Check size
- $250K-$1M
- HQ
- Singapore, Singapore
- Founded
- 2018
- Website
- https://www.verge.fund/
- LinkedIn
- https://linkedin.com/company/verge-healthtech-fund
- Twitter
- https://twitter.com/vergehealthtech
Institutional Investorhealthtechhealthcare SaaSdigital therapeuticsdigital health platformsclinical decision supportnext-gen diagnosticsbreakthrough smart devicesmedical devicesAI/data analytics in healthcare
What they look for
technology-centric solutions expanding healthcare access/quality/efficiency especially in emerging markets/LMICs; platforms scalable to millions; early revenue, pre-regulatory, R&D stages; geo-agnostic with focus on Asia/Europe; visionary, passionate founders; no biotech/invasive medtech/asset-heavy infra
📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.
⚠️ Common pitch mistakes we see →
Preparing to pitch Verge Fund?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →
